Aquestive Therapeutics AQST
$ 3.82
5.97%
Quarterly report 2024-Q3
added 11-04-2024
Aquestive Therapeutics General and Administrative Expenses 2011-2024 | AQST
Annual General and Administrative Expenses Aquestive Therapeutics
2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
---|---|---|---|---|---|---|---|---|---|---|---|---|
31.8 M | 52.9 M | 53.5 M | 55.9 M | 64.3 M | 72.3 M | 25.1 M | 20.8 M | - | - | - | - | - |
All numbers in USD currency
Indicator range from annual reports
Maximum | Minimum | Average |
---|---|---|
72.3 M | 20.8 M | 47.1 M |
Quarterly General and Administrative Expenses Aquestive Therapeutics
2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
12.1 M | 11.4 M | 10.7 M | - | 7.38 M | 7.36 M | 7.46 M | - | 12.5 M | 15.6 M | 13 M | - | 12.1 M | 13.1 M | 13.2 M | - | 11.8 M | 13.9 M | 14.6 M | - | 13.7 M | 16.2 M | 17.9 M | - | 12.3 M | 33.7 M | 7.57 M | - | 6.16 M | 5.22 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
All numbers in USD currency
Indicator range from quarterly reporting
Maximum | Minimum | Average |
---|---|---|
33.7 M | 5.22 M | 12.6 M |